Lidocaine Hydrochloride

CAS 6108-05-0 13 current records 4 historicalSmall Molecule

Who holds supplier records for Lidocaine Hydrochloride? 13 organisations hold a current record for Lidocaine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), China (3), Sweden (1), Taiwan (1) and 3 other countries (3).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Lidocaine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/lidocaine-hydrochloride

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Lidocaine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Lidocaine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (11)

Certificates of Suitability on the EDQM register for Lidocaine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. DezhouCN
CEP 2024-340 - Rev 01
Lidocaine hydrochloride monohydrate
Sept 2026—
APEX HEALTHCARE LIMITED AnkleshwarIN
CEP 2024-258 - Rev 00
Lidocaine hydrochloride monohydrate
Oct 2025—
HARMAN FINOCHEM LIMITED MumbaiIN
CEP 2015-044 - Rev 01
Lidocaine hydrochloride monohydrate
Apr 2025—
CHEMINO PHARMA LIMITED MumbaiIN
CEP 2021-084 - Rev 01
Lidocaine hydrochloride monohydrate
Apr 2025—
SWATI SPENTOSE PVT. LTD. MumbaiIN
CEP 2013-103 - Rev 04
Lidocaine hydrochloride monohydrate
Feb 2025—
VIWIT PHARMACEUTICAL CO. LTD TengzhouCN
CEP 2022-431 - Rev 00
Lidocaine hydrochloride monohydrate
Sept 2024—
Moehs Iberica S.L. RubiES
CEP 1996-020 - Rev 09
Lidocaine hydrochloride monohydrate
May 2024—
SOCIETÀ ITALIANA MEDICINALI SCANDICCI S.I.M.S. S.R.L ReggelloIT
CEP 2001-014 - Rev 04
Lidocaine hydrochloride monohydrate
Sept 2023Inspected Nov 2024
Italy
W. R. GRACE & CO.-CONN. ColumbiaUS
R1-CEP 2010-029 - Rev 02
Lidocaine hydrochloride monohydrate
Aug 2021—
CAMBREX KARLSKOGA AB KarlskogaSE
R1-CEP 2011-325 - Rev 02
Lidocaine hydrochloride monohydrate
Jun 2021—
DELTA SYNTHETIC CO., LTD. New Taipei CityTW
R1-CEP 2013-198 - Rev 00
Lidocaine hydrochloride monohydrate
Nov 2019—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Lidocaine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • KONDUSKAR LABORATORIES PVT LTD
    Inactive DMF 24056 · filed Aug 2010
  • GUFIC BIOSCIENCES LTD
    Inactive DMF 17483 · filed Jun 2004
  • NAPP CHEMICALS INC
    Inactive DMF 4182 · filed Jun 1981
  • SANOFI PHARMACEUTICALS INC
    Inactive DMF 2801 · filed Nov 1976

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Lidocaine Hydrochloride is a local anesthetic and antiarrhythmic drug used to numb tissue in a specific area and to treat ventricular arrhythmias. It works by blocking sodium channels, which inhibits nerve impulse initiation and conduction.

Chemical identity

IUPAC name
[2-(2,6-dimethylanilino)-2-oxoethyl]-diethylazanium;chloride;hydrate
Canonical SMILES
CC[NH+](CC)CC(=O)NC1=C(C=CC=C1C)C.O.[Cl-]
InChIKey
YECIFGHRMFEPJK-UHFFFAOYSA-N
Synonyms
Xylocaine API, akten, alphacaine hydrochloride, anestacon, hbn-1 component lidocaine hydrochloride, laryng-o-jet kit, laryngotracheal anesthesia kit, lidocaine hcl, lidocaine hydrochloride monohydrate, lidocaine hydrochloride usp, lidocaini hydrochloridum, lidocaton

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Amide Local Anesthetic; Antiarrhythmic
Physiologic effect
Local Anesthesia
Chemical structure
Amides

Therapeutic areas

AnesthesiologyCardiologyDermatology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Lidocaine Hydrochloride?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Lidocaine Hydrochloride: Apex Healthcare Limited (India), CAMBREX KARLSKOGA AB (Sweden), DELTA SYNTHETIC CO LTD (Taiwan), HARMAN FINOCHEM LTD (India), MOEHS IBERICA SL (Spain), SWATI SPENTOSE PRIVATE LTD (India), MAHENDRA CHEMICALS (India) and SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD (China), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Lidocaine Hydrochloride Drug Master Files are active?

Apex Healthcare Limited (DMF 39139, 34307), CAMBREX KARLSKOGA AB (DMF 19531), DELTA SYNTHETIC CO LTD (DMF 11338), HARMAN FINOCHEM LTD (DMF 28784), MOEHS IBERICA SL (DMF 5876), SWATI SPENTOSE PRIVATE LTD (DMF 25963), MAHENDRA CHEMICALS (DMF 24051) and SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD (DMF 40814) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Lidocaine Hydrochloride records mean?

4 organisations have only inactive Type II DMFs for Lidocaine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Lidocaine Hydrochloride have a European Certificate of Suitability?

Yes. 11 organisations hold a valid CEP for Lidocaine Hydrochloride on the EDQM register, including SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. Dezhou (CN), APEX HEALTHCARE LIMITED Ankleshwar (IN), HARMAN FINOCHEM LIMITED Mumbai (IN), CHEMINO PHARMA LIMITED Mumbai (IN), SWATI SPENTOSE PVT. LTD. Mumbai (IN) and VIWIT PHARMACEUTICAL CO. LTD Tengzhou (CN) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Lidocaine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Lidocaine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.